The Duke Sarcoma Research Program uses a multidisciplinary, patient-centric approach to diagnose and treat bone and soft-tissue sarcomas. Through unsurpassed clinical care, personalized treatment planning and delivery, and state-of-the-art basic scientific and clinical research, the program is the center of excellence for the treatment of sarcoma in the Southeast.
The leaders of the program are building both a basic / translational research program as well as growing the clinical research program. They want to have a clinical trial option for every patient.
Researchers in this program have conducted and are conducting several sarcoma-specific clinical trials, both investigator initiated and cooperative group sponsored trials. Their basic science research centers on mouse models of soft tissue sarcoma and rhabdomyosarcoma developed by members of the Duke Sarcoma Research Program.
Since 2007, researchers in the program have had 50 peer
review journal articles published and more than $11 million in
Recently, the group has: